Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix change
Authors:
- Chiharu KishimotoCKChiharu Kishimoto
- Nami TakamatsuNTNami Takamatsu
- Hiroshi KawamataHKHiroshi Kawamata
- Hiromichi ShinoharaHSHiromichi Shinohara
- Hiroshi OchiaiHOHiroshi Ochiai
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathyJACC, 2000
- Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of CardiomyopathiesCirculation, 1996
- Therapy With Immunoglobulin Suppresses Myocarditis in a Murine Coxsackievirus B3 ModelCirculation, 1995
- Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.Circulation, 1994
- Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure.Circulation, 1993
- Myocardial fibrin deposition in experimental viral myocarditis that progresses to dilated cardiomyopathy.Circulation Research, 1993
- Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis.Circulation Research, 1992
- Treatment of systemic vasculitis with pooled intravenous immunoglobulinThe Lancet, 1991
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986
- Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor AntibodyNew England Journal of Medicine, 1986